Quantitative Brain MRI Lesion Load Predicts the Course of Clinically Isolated Syndromes Suggestive of Multiple Sclerosis
Neurol 44:635-641, Felippi,M.,et al, 1994
Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome after Supratentorial Hemorrhagic Stroke
Stroke 25:1207-1210, Fukui,K.,et al, 1994
The Hidden Costs of Medicolegal Abuses in Neurology
Arch Neurol 51:650-652, Scheinberg,P., 1994
Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994
A Double-Blind, Placebo-Controlled Trial of Tizanidine in the Treatment of Spasticity Caused by Multiple Sclerosis
Neurol 44:S70-S78, Barnes,M.P.,et al, 1994
Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994
A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994
Chronic Spinal Cord Injury
NEJM 330:550-556, Ditunno,J.F.&Formal,C.S., 1994
Megadose Corticosteroids in Multiple Sclerosis
Neurol 44:1-4, Kupersmith,M.J.,et al, 1994
Value of Magnetic Resonance Imaging-Based Measurements of Hippocampal Formations in Patients with Partial Epilepsy
Arch Neurol 51:130-138, Adam,C.,et al, 1994
Cerebrospinal Fluid in the Diagnosis of Multiple Sclerosis:A consensus Report
JNNP 57:897-902, Andersson,M.,et al, 1994
Prognosis of Young Adults with Ischemic Stroke:Follow-up Assessing Recurrent Vascular Events & Funct Outcome
Stroke 25:1360-1365, Kappelle,L.J.,et al, 1994
Interrater Agreement in Evaluation of Stroke Patients with the Unified Neurological Stroke Scale
Stroke 25:1263-1264, Treves,T.A.,et al, 1994
Deep Gray Matter Involvement in Children with Acute Disseminated Encephalomyelitis
AJNR 15:1275-1283, Baum,P.A.,et al, 1994
Breast Feeding and Multiple Sclerosis
BMJ 308:1411-1412, Pisacane,A.,et al, 1994
Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994
Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994
Balo Concentric Sclerosis:MR Diagnosis
AJNR 15:1284-1285, Korte,J.H.,et al, 1994
Dementia in 2 Histologically Confirmed Cases of MS:One Isolated Dementia & One Assoc with Psychiatric Symptoms
JNNP 57:353-359, Fontaine,B.,et al, 1994
The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994
Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994
Clin & Path Features of an Autosomal Dominant, Adult-Onset Leukodystrophy Simul Chronic Progressive MS
Arch Neurol 51:757-766, Schwankhaus,J.D.,et al, 1994
Familial Alzheimer's Disease
Ann Neurol 36:335-336, Bird,T.D., 1994
Phenotype of Chromosome 14-Linked Familial Alzheimer's Disease in a Large Kindred
Ann Neurol 36:368-378, Lampe,T.H.,et al, 1994
Chromosome 14-Encoded Alzheimer's Disease:Genetic and Clinicopathological Description
Ann Neurol 36:362-367, Haltia,M.,et al, 1994
Familial Progressive Subcortical Gliosis
Neurol 44:1633-1643, Lanska,D.J.,et al, 1994
MR of Sarcoidosis in the Head and Spine:Spectrum of Manifestations and Radiographic Response to Steroid Therapy
AJNR 15:973-982, Lexa,F.J.&Grossman,R.I., 1994
Orbital and Optic Pathway Sarcoidosis:MR Findings
AJNR 15:775-783, Carmody,R.F.,et al, 1994
Antiphospholipid Antibody Syndrome Mimicking Multiple Sclerosis Clinically and by Magnetic Resonance Imaging
Arch Int Med 154:917-920, Scott,T.F.,et al, 1994
Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994
Long-Term Risk of Recurrent Stroke After a First-Ever Stroke:The Oxfordshire Community Stroke Project
Stroke 25:333-337, Burn,J.,et al, 1994
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994
Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994
Treatment of Multiple Sclerosis
Lancet 343:275-279, Ebers,G.C., 1994
4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety
Arch Neurol 51:292-296, Polman,C.H.,et al, 1994
A Genetic Marker and Family History Study of the Upstate New York Multiple Sclerosis Cluster
Neurol 44:329-333, Schiffer,R.B.,et al, 1994
The Value of Diagnostic Information to Patients with Suspected Multiple Sclerosis
Arch Neurol 51:67-72, Mushlin,A.I.,et al, 1994
Effect of Diagnostic Testing for Multiple Sclerosis on Patient Health Perceptions
Arch Neurol 51:46-51, O'Connor,P.,et al, 1994
Pathogenesis of Multiple Sclerosis
Lancet 343:271-275, Ffrench-Constant,C., 1994
The British Isles Survey of Multiple Sclerosis in Twins
Neurol 44:11-15, Mumford,C.J.,et al, 1994
Treatment of Paroxysmal Symptoms in Multiple Sclerosis with Ibuprofen
Neurol 44:571-572, Khan,O.A., 1994
Magnetic Resonance Evaluation of Disease Activity During Pregnancy in Multiple Sclerosis
Neurol 44:327-329, vanWalderveen,M.A.A.,et al, 1994
Concentric Sclerosis (Balo) :Morphometric and In Situ Hybridization Study of Lesions in Six Patients
Ann Neurol 35:18-30, Yao,D-L.,et al, 1994
Electroencephalography as an Aid in the Exclusion of Alzheimer's Disease
Arch Neurol 51:280-284, Robinson,D.J.,et al, 1994
Serial Neurologic Examinations After Near Drowning and Outcome
Arch Pediatr Adolesc Med 148:167-170, Bratton,S.L.,et al, 1994
Spontaneous Palpebromandibular Synkinesia:A Localizing Clinical Sign
Ann Neurol 35:222-228, Pullicino,P.M.,et al, 1994
Posttraumatic Headache
Semin Neurol 14:40-45, Packard,R.C., 1994
Mild Head Injury
(Ed) , Semin Neurol 14:1-9294., Packard,R.C., 1994
Regional Brain Abnormalities in Schizophrenia Measured with Magnetic Resonance Imaging
JAMA 272:1763-1769, Andreasen,N.C.,et al, 1994